Abstract
Background
Lesion patterns may predict prognosis after acute ischemic stroke within the middle cerebral artery (MCA) territory; yet it remains unclear whether such imaging prognostic factors are related to patient outcome after intravenous thrombolysis.
Aims
The aim of this study is to investigate the clinical outcome after intravenous thrombolysis in acute MCA ischemic strokes with respect to diffusion-weighted imaging (DWI) lesion patterns.
Methods
Consecutive acute ischemic stroke cases of the MCA territory treated over a 7-year period were retrospectively analyzed. All acute MCA stroke patients underwent a MRI scan before intravenous thrombolytic therapy was included. DWI lesions were divided into 6 patterns (territorial, other cortical, small superficial, internal border zone, small deep, and other deep infarcts). Lesion volumes were measured by dedicated imaging processing software. Favorable outcome was defined as modified Rankin scale (mRS) of 0–2 at 90 days.
Results
Among the 172 patients included in our study, 75 (43.6%) were observed to have territorial infarct patterns or other deep infarct patterns. These patients also had higher baseline NIHSS score (p < 0.001), a higher proportion of large cerebral artery occlusions (p < 0.001) and larger infarct volume (p < 0.001). Favorable outcome (mRS 0–2) was achieved in 89 patients (51.7%). After multivariable analysis, groups with specific lesion patterns, including territorial infarct and other deep infarct pattern, were independently associated with favorable outcome (OR 0.40; 95% CI 0.16–0.99; p = 0.047).
Conclusions
Specific lesion patterns predict differential outcome after intravenous thrombolysis therapy in acute MCA stroke patients.
Keywords: Acute ischemic stroke, Thrombolysis, MRI, Clinical outcome
Introduction
Intravenous thrombolysis with tissue-type plasminogen activator (IV-tPA) is a well-proved treatment in ischemic stroke patients presenting within 4.5 h from symptoms onset [1, 2]. After thrombolytic therapy, recanalization is achieved only in 40% of middle cerebral artery (MCA) stroke patients [3] and half of these patients remain severely disabled or die [4]. Therefore, it is of great importance to identify the factors that predict clinical outcome after intravenous thrombolysis among acute MCA ischemic stroke patients [5]. Imaging-guided patient selection was successfully used in selecting patients for endovascular therapy. Several imaging factors [6] have been analyzed to determine whether they can predict outcome after intravenous thrombolysis in acute MCA stroke patients, including length of occlusion and distribution of occlusion. However, the definitions used for the MCA segments are variable in different studies and measure the length of occlusion can't be used in all centers. It is therefore important to develop a standard time and cost-effective imaging analysis method that can predict clinical outcome in these patients.
Being the most sensitive diagnostic modality in detecting acute ischemic lesions, diffusion-weighted imaging (DWI) can provide several important inputs for clinical analysis [7, 8]. Among them, DWI lesion pattern analysis is considered a simple and reasonable method to predict patients’ clinical outcome. Previous studies [9, 10] have demonstrated that lesion patterns identified on DWI are correlated with the pathogenic mechanisms. The predictor role of lesion patterns to clinical outcome has also been proved in acute MCA ischemic stroke patients [5, 11]. However, little is known about whether MCA stroke patients treated with intravenous thrombolysis have different outcomes based on different lesion patterns.
In this study, we hypothesized that outcome after intravenous thrombolysis in patients with acute MCA ischemic stroke varies depending on lesion patterns. In particular, we investigated clinical and imaging predictors of poor response to systemic thrombolysis and evaluated whether patient outcome differs depending on infarct patterns.
Patients and Methods
Study Design
We performed a retrospective study on a cohort of patients diagnosed with an acute ischemic stroke and treated with IV-tPA. We reviewed all patients’ imaging data from UCLA at the Neurovascular Imaging Research Core. In this analysis, we included only acute ischemic stroke patients with lesions involving MCA territory or border-zone areas. Clinical and imaging data were obtained from every patient with their informed consent and approval of the Ethic Committee. We excluded patients who (1) were <18 years old, (2) had infarcts in multiple vascular territories beyond the unilateral MCA territory, (3) had no MRI results before intravenous thrombolysis, (4) had no MRA, CTA or conventional angiography results to determine the occlusion of carotid artery or MCA, (5) had lost follow-up data.
Data on clinical history, demographics, laboratory results, vascular risk factors were obtained as part of routine stroke care. Baseline stroke severity was assessed with the National Institutes of Health Stroke Scale (NIHSS) score. At the third-month follow-up, patients were interviewed in the outpatient clinic or through the telephone to evaluate clinical outcome in terms of the level of independence in performing the activities of daily living. Favorable outcome at 3 months was defined as modified Rankin scale (mRS) score ≤2.
Imaging Analysis
Emergency MRI was performed on a 3.0-T scanner. The MR protocol included DWI (single-shot echo-planar spin-echo sequence; 3 directions, b = 1,000), T2-weighted imaging and MR angiography. The topography of ischemic lesions was determined using published templates [12]. The MCA territory was divided into 3 subdivisions: deep territory, superficial anterior territory and superficial posterior territory. Patients were divided into 6 groups based on DWI patterns [13]. Territorial infarcts were infarcts involving 2 or more subdivisions. Other cortical infarcts were cortical infarcts involving one subdivision or cortical border zone. Small superficial infarcts were multiple small cortical infarcts (diameter <10 mm), or single or multiple superficial infarcts in the centrum ovale. Internal border zone infarcts were defined as multilocular chain-like lesions, confluent striated lesion patterns, or solitary lesions located in the supraventricular or paraventricular areas. Small deep infarcts were the small striato-capsular lesions involving striato-capsular area. Other deep infarcts were large striato-capsular lesions or concomitant DWI lesions outside the striato-capsular area. Lesion patterns were analyzed by two-stroke imaging experts (D.L. and F.S.), who were blinded to the clinical characteristics. Discrepancies were resolved by consensus.
In this study, we included only those patients with vascular results, including MRA, CTA or DSA, to determine the occlusion of cerebral vascular. Large cerebral artery occlusion was defined as internal carotid artery occlusion or M1 segment of MCA occlusion. One of the authors blinded to the clinical information analyzed the lesion volumes using a computer-assisted volumetric analysis program (Olea Medical, La Ciotat, France). DWI lesion volumes were quantified from the analysis of isotropic b1000 images and ADC maps with threshold ADC <600. Lesions visible on DWI images were semi-automatically segmented using Osirix software. The final 3D volume was then computed using linear interpolation between slice and the slice spacing to obtain accurate estimates.
Statistical Analysis
Continuous variables with a normal distribution were described in terms of their mean and SD. Non-normally distributed variables were described as median and interquartile range (IQR). Continuous variables were compared with Mann–Whitney U test and categorical variables were compared using Pearson χ2 or Fisher exact test, as appropriate. Logistic regression analyses were done to determine the independent predictors of favorable outcome at 90 days (mRS 0–2). All covariates with a p value <0.1 in a univariate analysis were entered into this logistic regression model and a value of p <0.05 was used to indicate statistical significance.
Results
Patients Characteristics at Baseline
During January 2007 and December 2013, a total of 172 patients met the inclusion criteria and were enrolled in this study. Baseline characteristics for the cohort are shown in table 1. The mean age was 67.0 ± 16.4 years with 44.8% being male patients. The median baseline NIHSS score was 13 (IQR 7–18) and onset to treatment time was 132.9 ± 48.7 min.
Table 1.
Patient characteristics grouped by lesion patterns
A – territorial infarcts (n = 34) | B – small superficial infarcts (n = 31) | C – other cortical infarcts (n = 37) | D – internal border zone infarcts (n = 10) | E – small deep infarcts (n = 19) | F – other deep infarcts (n = 41) | |
---|---|---|---|---|---|---|
Age, mean ± SD | 62.6±16.9 | 67.8±15.0 | 65.6±16.7 | 72.1±17.1 | 67.5±15.9 | 69.7±16.7 |
Male, n (%) | 15 (44.1) | 18 (58.1) | 16 (43.2) | 4 (40.0) | 7 (36.8) | 17 (41.5) |
Risk factors, n (%) | ||||||
Hypertension | 20 (58.8) | 21 (67.7) | 28 (75.7) | 8 (80.0) | 14 (73.7) | 24 (58.5) |
Diabetes | 7 (20.6) | 7 (22.6) | 3 (8.1) | 3 (30.0) | 3 (15.8) | 9 (22.0) |
Hyperlipidemia | 14 (41.2) | 14 (45.2) | 20 (54.1) | 3 (30.0) | 9 (47.4) | 21 (51.2) |
Ever smoker | 5 (14.7) | 1 (3.2) | 5 (13.5) | 2 (20.0) | 1 (5.3) | 5 (12.2) |
Previous stroke/TIA | 7 (20.6) | 7 (22.6) | 9 (24.3) | 4 (40.0) | 5 (26.3) | 6 (14.6) |
CAD | 5 (14.7) | 0 (0)* | 6 (16.2) | 1 (10.0) | 2 (10.5) | 4 (9.8) |
Heart failure | 3 (8.8) | 1 (3.2) | 6 (16.2)* | 1 (10.0) | 0 (0) | 3 (7.3) |
AF | 10 (29.4) | 10 (32.3) | 11 (29.7) | 5 (50.0) | 2 (10.5) | 8 (19.5) |
Baseline NIHSS score, median (IQR) | 18.0 (14.0–21.0)* | 8.0 (4.0–15.0)* | 10.0 (4.5–15.5)* | 8.5 (4.5–15.0) | 7.0 (5.0–10.0)* | 15.0 (12.0–21.0)* |
SBP, mm Hg, median (IQR) | 152.0±26.7 | 143.2±28.7* | 155.0±23.3 | 165.1±37.2 | 152.3±32.7 | 160.5±27.4 |
Blood glucose, mg/dl, median (IQR) | 132.0±31.8 | 125.0±37.0 | 118.9±24.3* | 145.1±43.6 | 123.5±25.7 | 134.3±42.5 |
Cholesterol | 164.8±39.1 | 157.0±47.8 | 167.3±44.2 | 174.7±42.0 | 170.8±43.1 | 161.2±37.7 |
Onset to therapy time | 127.7±44.9 | 134.2±47.5 | 146.3±49.3 | 139.3±67.9 | 145.1±49.9 | 117.1±43.9* |
Need more therapy, n (%) | 20 (58.8)* | 7 (22.6)* | 8 (21.6)* | 3 (30.0) | 6 (31.6) | 23 (56.1)* |
Large cerebral artery occlusion | 22 (64.7)* | 5 (16.1)* | 6 (16.2)* | 5 (50.0) | 5 (26.3) | 27 (65.9)* |
Infarction volume on DWI | 98.8 (73.3–146.9) | 5.2 (3.7–7.4)* | 66.5 (32.1–86.6)* | 15.5 (13.0–20.7) | 3.0 (2.8–3.1)* | 19.6 (14.8–46.7) |
90 days mRS ≤2 | 11 (32.4)* | 19 (61.3) | 24 (64.9) | 7 (70.0) | 13 (68.4) | 15 (36.6)* |
TIA = Transient ischemic attack; CAD = coronary artery disease; AF = atrial fibrillation.
p < 0.05.
According to the different lesion patterns, patients with territorial infarcts (34/172, 19.8%) have a higher baseline NIHSS score (18.0 vs. 11.0, p < 0.001), a higher proportion of large cerebral artery occlusion (64.7 vs. 34.8%, p = 0.001) and a larger infarct volume (98.8 (73.3–146.9) vs. 14.3 (5.2–37.4), p < 0.001). Although territorial infarct patients were more likely to undergo an endovascular therapy (58.8 vs. 34.1%, p = 0.008), the percentage of patients with favorable outcome is significantly lower than others (32.4 vs. 56.5%, p = 0.012). Patients with small superficial infarcts (31/172, 18%) had a lower baseline NIHSS score (p = 0.003), reduced large cerebral artery occlusion (p = 0.002), smaller infarct volume (p < 0.001) and were less likely to undergo endovascular therapy (p = 0.039). Similarly to the small superficial infarct group, patients with other cortical infarct pattern also demonstrated a lower baseline NIHSS score (10.0 vs. 13.0, p = 0.035). In addition, endovascular therapy was less likely (21.6 vs. 43.7%, p = 0.015), large cerebral artery occlusion was less frequent (16.2 vs. 47.4%, p = 0.001), and infarct volume was larger (66.5 (32.1–86.6) vs. 16.2 (5.1–64.8), p = 0.005).
There was another deep infarct (41/172, 23.8%) that was the most popular lesion pattern in our study. The baseline NIHSS score of these patients was higher than others (15.0 vs. 11.0, p = 0.001) and more patients had large cerebral artery occlusions (65.9 vs. 32.8%, p < 0.001). In our analysis, more patients with other deep infarcts underwent endovascular therapy (56.1 vs. 33.6%, p = 0.010) and the onset to therapy time was shorter (117.1 ± 43.9 vs. 137.9 ± 49.3, p = 0.016). As expected, the proportion of patients good outcome at 90 days (mRS ≤3) in this group was smaller than others (36.6 vs. 56.5%, p = 0.026).
Baseline Characteristics in Different Groups
Based on lesion pattern analysis results, the patients included in our study were divided into 2 different groups. Territorial infarct patients and other deep infarct patients were located in Group 1 (75/172, 43.6%), while the patients for the other 4 lesion patterns were located in Group 2. The characteristics of different groups are shown in table 2.
Table 2.
Patient characteristics grouped by the lesion pattern subset
Characteristics | Group 1 (n = 75) Infarction pattern – A + F | Group 2 (n = 97) Infarction pattern – B + C + D + E | p value |
---|---|---|---|
Age, mean ± SD | 66.5±17.1 | 67.3±15.9 | 0.734 |
Male, n (%) | 32 (42.7) | 45 (46.4) | 0.626 |
Risk factors, n (%) | |||
Hypertension | 44 (58.7) | 71 (73.2) | 0.045* |
Diabetes | 16 (21.3) | 16 (16.5) | 0.419 |
Hyperlipidemia | 35 (46.7) | 46 (47.4) | 0.922 |
Ever smoker | 10 (13.3) | 9 (9.3) | 0.400 |
Previous stroke/TIA | 13 (17.3) | 25 (25.8) | 0.186 |
CAD | 9 (12.0) | 9 (9.3) | 0.563 |
Heart failure | 6 (8.0) | 8 (8.2) | 0.953 |
AF | 18 (24.0) | 28 (28.9) | 0.475 |
Baseline NIHSS score, median (IQR) | 17.0 (13.0–21.0) | 8.0 (5.0–15.0) | <0.001* |
SBP, mm Hg, median (IQR) | 156.7±27.3 | 151.8±28.9 | 0.260 |
Blood glucose, mg/dl, median (IQR) | 133.3±37.8 | 124.5±31.8 | 0.099 |
Cholesterol | 162.8±38.1 | 165.5±44.7 | 0.680 |
Onset to therapy time | 121.9±44.4 | 141.5±50.5 | 0.008* |
Need more therapy, n (%) | 43 (57.3) | 24 (24.7) | <0.001* |
Large cerebral artery occlusion | 49 (65.3) | 21 (21.6) | <0.001* |
Infarction volume on DWI | 55.3 (19.3–91.0) | 8.6 (3.3–28.2) | <0.001* |
90 days mRS ≤2 | 26 (34.7) | 63 (64.9) | <0.001* |
TIA = Transient ischemic attack; CAD = coronary artery disease; AF = atrial fibrillation.
p < 0.05.
The history of hypertension is less frequent in Group 1 than Group 2 (p = 0.045). Other risk factors and baseline characteristics (including systolic blood pressure (SBP), blood glucose and cholesterol) were not significantly different in the 2 groups. The neurological symptoms of Group 1 were more severe than that of Group 2 (p < 0.001). As to imaging analysis, large cerebral artery occlusions were more frequent (p < 0.001) and infarct volumes were larger (p < 0.001) in Group 1. The patients in Group 1 had a less favorable outcome (34.7 vs. 64.9%, p < 0.001) even though they were more likely to undergo an endovascular therapy (p < 0.001) and had a shorter onset-therapy time (p = 0.008).
Associative Factors of 90 Days Clinical Outcome
In our study, a favorable outcome (mRS 0–2) was observed in 89 patients (51.7%). Table 3 shows the potential predictors of clinical outcomes. The patients with a favorable outcome were significantly younger than those with a poor outcome (p < 0.001). The group with a favorable outcome also had a lower baseline NIHSS score (p < 0.001), lower proportion of large cerebral artery occlusion (p = 0.004), smaller infarct volume (p = 0.029) and less territorial infarct or other deep infarct (p < 0.001). After univariate analysis, the percent of endovascular therapy (p = 0.076) were included in multivariate logistic regression. The result of multivariate logistic regression is shown in table 3. After adjustment for confounding factors, special lesion patterns, including territorial infarct patterns and other deep infarct patterns, were independently associated with a favorable outcome (OR 0.40; 95% CI 0.16–0.99; p = 0.047).
Table 3.
Patient characteristics grouped by 90 days outcomes
Characteristics | Patients with favorable outcome mRS <3 (n = 89) | Patients with poor outcome mRS ≥3 (n = 83) | p value | OR | 95% CI | p value |
---|---|---|---|---|---|---|
Age, mean ± SD | 61.8±15.4 | 72.5±15.7 | <0.001* | 0.96 | 0.94–0.98 | <0.001* |
Male, n (%) | 44 (49.4) | 33 (39.8) | 0.202 | |||
Risk factors, n (%) | ||||||
Hypertension | 55 (61.8) | 60 (72.3) | 0.144 | |||
Diabetes | 15 (16.9) | 17 (20.5) | 0.541 | |||
Hyperlipidemia | 42 (47.2) | 39 (47.0) | 0.979 | |||
Ever smoker | 8 (9.0) | 11 (13.3) | 0.373 | |||
Previous stroke/TIA | 16 (18.0) | 22 (26.5) | 0.178 | |||
CAD | 11 (12.4) | 7 (8.4) | 0.401 | |||
Heart failure | 7 (7.9) | 7 (8.4) | 0.892 | |||
AF | 21 (23.6) | 25 (30.1) | 0.334 | |||
Baseline NIHSS score, median (IQR) | 9.0 (4.0–15.5) | 16.0 (11.0–20.0) | <0.001* | 0.95 | 0.89–1.00 | 0.045* |
SBP, mm Hg, median (IQR) | 150.6±26.7 | 157.4±29.5 | 0.115 | |||
Blood glucose, mg/dl, median (IQR) | 125.6±34.2 | 131.3±35.2 | 0.284 | |||
Cholesterol | 168.1±43.8 | 160.2±39.6 | 0.219 | |||
Onset to therapy time | 135.2±54.3 | 130.5±42.2 | 0.521 | |||
Need more therapy, n (%) | 29 (32.6) | 38 (45.8) | 0.076* | 1.08 | 0.52–2.27 | 0.836 |
Large cerebral artery occlusion | 27 (30.3) | 43 (51.8) | 0.004* | 1.37 | 0.64–2.97 | 0.421 |
Infarction volume on DWI | 17.1 (5.0–46.2) | 35.3 (8.3–73.2) | 0.029* | 1.00 | 0.99–1.01 | 0.998 |
Patients in infarction pattern group 1 (infarction pattern A + F) | 26 (29.2) | 49 (59.0) | <0.001* | 0.40 | 0.16–0.99 | 0.047* |
TIA = Transient ischemic attack; CAD = coronary artery disease; AF = atrial fibrillation.
Discussion
The results of our study demonstrated that patients with territorial infarct pattern or other deep infarct pattern were more likely to have larger lesion volume, more cerebral artery occlusion, higher chance of undergoing an endovascular therapy and shorter onset to therapy time, in acute MCA stroke patients with intravenous thrombolysis. The presence of these specific lesion patterns was independently associated with poor outcome after IV-tPA in these patients.
Three thrombectomy clinical trials published in 2013, IMS III [14], MR RESCUE [15] and SYNTHESIS [16], reported neutral results on clinical outcome. However, the results from recent clinical trials [17–19] provided good evidence for early thrombectomy with stent retrievers. The use of imaging criteria to select patients might be one of the most important explanations for that difference. In ESCAPE trials [18], only patients with a CTA-confirmed occlusion of the carotid T or the MCA, good collaterals on multiphase CTA, and a CT-ASPECTS >5 were included. The MR CLEAN trial subgroup analysis [17] also showed the benefit of thrombectomy for patients with ASPECT scores ≥5 points but probably not with ASPECT scores between 0 and 4. Therefore, it is well accepted that infarct volume is an important criterion needed to select patients for endovascular therapy. A previous study [20] has found that patients with large deep white matter lesion on DWI were poor candidates for endovascular therapy. In this study, patients with territorial infarct or other deep infarct patterns had larger infarct volume than others. Although more endovascular therapies were performed, their clinical outcome was still worse than others, and the independent association of endovascular therapy with clinical outcome was not tested. Then, our result is in agreement with the consensus that large infarct is unsuitable for thrombectomy.
DWI infarct volume has also been proved to predict short-term recovery in patients with MCA occlusion who underwent intravenous thrombolysis [21] or endovascular therapy [22]. However, another study [6] found that cerebral blood volume ASPECTS score is not the independent predictor of clinical outcome after intravenous thrombolysis in MCA ischemic stroke patients. In our study, infarct volume was also not the independent predictor of patients’ clinical outcome. We assumed that the progression of DWI infarct volume accounted for the controversy. DWI-PWI (perfusion-weighted imaging) mismatch presents in some patients, and lesions on early DWI may result in a significant increase on follow-up image [7, 23]. A previous study [24] has demonstrated that the degree of increase in DWI volume differed depending on the DWI lesion pattern, and small DWI lesion volume could have poorer prognosis in special lesion pattern. Therefore, lesion patterns can play a powerful predictor role by combination of baseline lesion volume and progression of lesion volume.
In a rodent model for ischemic stroke, different ADC patterns were related to different functional outcomes in lesions of similar size after permanent MCA occlusion [25]. For clinical patients, DWI lesion pattern analysis is also considered a simple and reasonable method to predict patient outcome [13]. In addition to this, likely mechanisms of stroke can be explored through lesion pattern analysis and the recurrence of stroke varied according to different lesion patterns [10]. Also, lesion pattern analysis is feasible for clinical practice because it is less time consuming and more reliable for neurologist. Bang et al. [13] found that DWI lesion patterns predict prognosis after acute ischemic stroke within the MCA territory. Another study [26] also demonstrated that specific lesion patterns were related to cerebral arterial occlusion mechanisms and were correlated with functional outcome. Lesion patterns on DWI might be a clue for determining ischemic stroke etiology on patients with MCA occlusion. Similar to these studies, our study has proved that DWI lesion patterns independently predicted the clinical outcome of acute MCA ischemic stroke patients after IV-tPA treatment.
There are some limitations to our study. First, this study is a single-center, retrospective study. The number of patients is comparatively smaller for complex analyses. Our results remain to be confirmed in larger multicenter trials. Accordingly, the lesion patterns were analyzed by stroke imaging experts. To reduce inter-reader variability and to enable the systematic analysis of a large dataset, there is an overt need for an automatic tool that would be able to classify lesions accurately in the blink of an eye.
In conclusion, we found that lesion patterns were independent predictors of clinical outcome in patients with acute MCA stroke after intravenous thrombolysis. Because the pathophysiologic mechanisms of ischemic stroke vary in different lesion patterns, more aggressive endovascular reperfusion treatment should be considered according to special lesion patterns. Future clinical trials on mechanical thrombectomy could include lesion patterns as one of the patient selection criteria.
Acknowledgments
UCLA-Jinling Neurovascular Imaging Research Collaborators: D. Liu, MD; F. Scalzo, PhD; Wusheng Zhu, MD, PhD; Minmin Ma, MD, PhD; Wenhua Liu, MD, PhD; Yunyun Xiong, MD, PhD; Wen Sun, MD, PhD; Qiliang Dai, MD, PhD; S. Starkman, MD; N.M. Rao, MD; J.D. Hinman, MD; D. Kim, MD; L.K. Ali, MD; J.L. Saver, MD; A.R. Noorian, MD; K. Ng, MD; C. Liang, MD; S.A. Sheth, MD; B. Yoo, MD; Gelin Xu, MD, PhD; Renliang Zhang, MD, PhD; X. Liu, MD, PhD; D.S. Liebeskind, MD.
Sources of Funding
This study was supported by grants from National Natural Science Foundation of China (grant No. 81220108008 and 81000501), Jinling Hospital Medical Scientific Research Projects (2012003), and Clinical Medical Center Program of Jiangsu Province (Neurology Center).
Footnotes
Disclosure Statement
All authors have no conflict of interest.
References
- 1.Yoo J, Song D, Lee K, Kim YD, Nam HS, Heo JH. Comparison of outcomes after reperfusion therapy between in-hospital and out-of-hospital stroke patients. Cerebrovasc Dis. 2015;40:28–34. doi: 10.1159/000381787. [DOI] [PubMed] [Google Scholar]
- 2.Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D. ECASS Investigators: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–1329. doi: 10.1056/NEJMoa0804656. [DOI] [PubMed] [Google Scholar]
- 3.Alexandrov AV. Ultrasound identification and lysis of clots. Stroke. 2004;35(11 suppl 1):2722–2725. doi: 10.1161/01.STR.0000143321.37482.b3. [DOI] [PubMed] [Google Scholar]
- 4.Abilleira S, Ribera A, Davalos A, Ribo M, Chamorro A, Cardona P, Molina CA, Martínez-Yélamos A, Urra X, Dorado L, Roquer J, Marti-Fàbregas J, Aja L, Tomasello A, Castaño C, Blasco J, Cánovas D, Castellanos M, Krupinski J, Guimaraens L, Perendreu J, Ustrell X, Purroy F, Gómez-Choco M, Baiges JJ, Cocho D, Saura J, Gallofré M. Catalan Stroke Code and Reperfusion Consortium: Functional outcome after primary endovascular therapy or IV thrombolysis alone for stroke. An observational, comparative effectiveness study. Cerebrovasc Dis. 2014;38:328–336. doi: 10.1159/000368433. [DOI] [PubMed] [Google Scholar]
- 5.Tamura A, Yamamoto Y, Nagakane Y, Takezawa H, Koizumi T, Makita N, Makino M. The relationship between neurological worsening and lesion patterns in patients with acute middle cerebral artery stenosis. Cerebrovasc Dis. 2013;35:268–275. doi: 10.1159/000348313. [DOI] [PubMed] [Google Scholar]
- 6.Rohan V, Baxa J, Tupy R, Cerna L, Sevcik P, Friesl M, Polivka J, Jr, Polivka J, Ferda J. Length of occlusion predicts recanalization and outcome after intravenous thrombolysis in middle cerebral artery stroke. Stroke. 2014;45:2010–2017. doi: 10.1161/STROKEAHA.114.005731. [DOI] [PubMed] [Google Scholar]
- 7.van Everdingen KJ, van der Grond J, Kappelle LJ, Ramos LM, Mali WP. Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke. 1998;29:1783–1790. doi: 10.1161/01.str.29.9.1783. [DOI] [PubMed] [Google Scholar]
- 8.Kvistad CE, Logallo N, Thomassen L, Moen G, Waje-Andreassen U, Naess H. Diffusion-weighted lesions in stroke patients with transient symptoms –where are they located? Cerebrovasc Dis. 2014;38:219–225. doi: 10.1159/000366264. [DOI] [PubMed] [Google Scholar]
- 9.Choi JW, Kim JK, Choi BS, Lim HK, Kim SJ, Kim JS, Suh DC. Angiographic pattern of symptomatic severe M1 stenosis: comparison with presenting symptoms, infarct patterns, perfusion status, and outcome after recanalization. Cerebrovasc Dis. 2010;29:297–303. doi: 10.1159/000275508. [DOI] [PubMed] [Google Scholar]
- 10.Lopez-Cancio E, Matheus MG, Romano JG, Liebeskind DS, Prabhakaran S, Turan TN, Cotsonis GA, Lynn MJ, Rumboldt Z, Chimowitz MI. Infarct patterns, collaterals and likely causative mechanisms of stroke in symptomatic intracranial atherosclerosis. Cerebrovasc Dis. 2014;37:417–422. doi: 10.1159/000362922. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Liu D, Li Y, Shi Z, Davis SM, Wong KS, Leung TW, Yan B, Xiong Y, Sun W, Xu G, Zhang R, Liu X. Presence of anterior temporal artery associates with good outcome in acute athero-sclerotic M1-middle cerebral artery occlusion. Neuroradiology. 2014;56:1023–1030. doi: 10.1007/s00234-014-1422-3. [DOI] [PubMed] [Google Scholar]
- 12.Heinsius T, Bogousslavsky J, Van Melle G. Large infarcts in the middle cerebral artery territory. Etiology and outcome patterns. Neurology. 1998;50:341–350. doi: 10.1212/wnl.50.2.341. [DOI] [PubMed] [Google Scholar]
- 13.Bang OY, Lee PH, Heo KG, Joo US, Yoon SR, Kim SY. Specific DWI lesion patterns predict prognosis after acute ischaemic stroke within the MCA territory. J Neurol Neurosurg Psychiatry. 2005;76:1222–1228. doi: 10.1136/jnnp.2004.059998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, Silver FL, von Kummer R, Molina CA, Demaerschalk BM, Budzik R, Clark WM, Zaidat OO, Malisch TW, Goyal M, Schonewille WJ, Mazighi M, Engelter ST, Anderson C, Spilker J, Carrozzella J, Ryckborst KJ, Janis LS, Martin RH, Foster LD, Tomsick TA. Interventional Management of Stroke (IMS) III Investigators: Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368:893–903. doi: 10.1056/NEJMoa1214300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, Feng L, Meyer BC, Olson S, Schwamm LH, Yoo AJ, Marshall RS, Meyers PM, Yavagal DR, Wintermark M, Guzy J, Starkman S, Saver JL. MR RESCUE Investigators: A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368:914–923. doi: 10.1056/NEJMoa1212793. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R, Boccardi E. SYNTHESIS Expansion Investigators: Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013;368:904–913. doi: 10.1056/NEJMoa1213701. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, Schonewille WJ, Vos JA, Nederkoorn PJ, Wermer MJ, van Walderveen MA, Staals J, Hofmeijer J, van Oostayen JA, Lycklama a Nijeholt GJ, Boiten J, Brouwer PA, Emmer BJ, de Bruijn SF, van Dijk LC, Kappelle LJ, Lo RH, van Dijk EJ, de Vries J, de Kort PL, van Rooij WJ, van den Berg JS, van Hasselt BA, Aerden LA, Dallinga RJ, Visser MC, Bot JC, Vroomen PC, Eshghi O, Schreuder TH, Heijboer RJ, Keizer K, Tielbeek AV, den Hertog HM, Gerrits DG, van den Berg-Vos RM, Karas GB, Steyerberg EW, Flach HZ, Marquering HA, Sprengers ME, Jenniskens SF, Beenen LF, van den Berg R, Koudstaal PJ, van Zwam WH, Roos YB, van der Lugt A, van Oostenbrugge RJ, Majoie CB, Dippel DW. MR CLEAN Investigators: A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20. doi: 10.1056/NEJMoa1411587. [DOI] [PubMed] [Google Scholar]
- 18.Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, Roy D, Jovin TG, Willinsky RA, Sapkota BL, Dowlatshahi D, Frei DF, Kamal NR, Montanera WJ, Poppe AY, Ryckborst KJ, Silver FL, Shuaib A, Tampieri D, Williams D, Bang OY, Baxter BW, Burns PA, Choe H, Heo JH, Holmstedt CA, Jankowitz B, Kelly M, Linares G, Mandzia JL, Shankar J, Sohn SI, Swartz RH, Barber PA, Coutts SB, Smith EE, Morrish WF, Weill A, Subramaniam S, Mitha AP, Wong JH, Lowerison MW, Sajobi TT, Hill MD. ESCAPE Trial Investigators: Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–1030. doi: 10.1056/NEJMoa1414905. [DOI] [PubMed] [Google Scholar]
- 19.Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, Yan B, Dowling RJ, Parsons MW, Oxley TJ, Wu TY, Brooks M, Simpson MA, Miteff F, Levi CR, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Priglinger M, Ang T, Scroop R, Barber PA, Mc-Guinness B, Wijeratne T, Phan TG, Chong W, Chandra RV, Bladin CF, Badve M, Rice H, de Villiers L, Ma H, Desmond PM, Donnan GA, Davis SM. EXTEND-IA Investigators: Endovascular therapy for ischemic stroke with per-fusion-imaging selection. N Engl J Med. 2015;372:1009–1018. doi: 10.1056/NEJMoa1414792. [DOI] [PubMed] [Google Scholar]
- 20.Tateishi Y, Wisco D, Aoki J, George P, Katzan I, Toth G, Hui F, Hussain MS, Uchino K. Large deep white matter lesions may predict futile recanalization in endovascular therapy for acute ischemic stroke. Interv Neurol. 2015;3:48–55. doi: 10.1159/000369835. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Aoki J, Kimura K, Shibazaki K, Sakamoto Y. DWI-ASPECTS as a predictor of dramatic recovery after intravenous recombinant tissue plasminogen activator administration in patients with middle cerebral artery occlusion. Stroke. 2013;44:534–537. doi: 10.1161/STROKEAHA.112.675470. [DOI] [PubMed] [Google Scholar]
- 22.Olivot JM, Mosimann PJ, Labreuche J, Inoue M, Meseguer E, Desilles JP, Rouchaud A, Klein IF, Straka M, Bammer R, Mlynash M, Amarenco P, Albers GW, Mazighi M. Impact of diffusion-weighted imaging lesion volume on the success of endovascular reperfusion therapy. Stroke. 2013;44:2205–2211. doi: 10.1161/STROKEAHA.113.000911. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Tong DC, Yenari MA, Albers GW, O'Brien M, Marks MP, Moseley ME. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology. 1998;50:864–870. doi: 10.1212/wnl.50.4.864. [DOI] [PubMed] [Google Scholar]
- 24.Liebeskind DS, Jahan R, Nogueira RG, Jovin TG, Lutsep HL, Saver JL. SWIFT Investigators: Serial Alberta stroke program early CT score from baseline to 24 hours in solitaire flow restoration with the intention for thrombectomy study: a novel surrogate end point for revascularization in acute stroke. Stroke. 2014;45:723–727. doi: 10.1161/STROKEAHA.113.003914. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Lestro Henriques I, Gutiérrez-Fernández M, Rodriguez-Frutos B, Ramos-Cejudo J, Otero-Ortega L, Navarro Hernanz T, Cerdan S, Ferro JM, Díez-Tejedor E. Intralesional patterns of MRI ADC maps predict outcome in experimental stroke. Cerebrovasc Dis. 2015;39:293–301. doi: 10.1159/000381727. [DOI] [PubMed] [Google Scholar]
- 26.Lee KJ, Jung KH, Byun JI, Kim JM, Roh JK. Infarct pattern and clinical outcome in acute ischemic stroke following middle cerebral artery occlusion. Cerebrovasc Dis. 2014;38:31–38. doi: 10.1159/000364939. [DOI] [PubMed] [Google Scholar]